Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar 13 in Chinese Infants and Children 6 Weeks to <6 Years
CTR20171481Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by Pfizer. Started Jun 2018; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on CTR20171481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171481.